Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cord Blood Transplantation Using Myeloablative Conditioning for Pediatric Advanced Myelodysplastic Syndrome in AMeD Syndrome With a Novel ADH5 Variant.
Morishita Y, Hamada M, Uemura S, Kikuchi H, Hisakawa H, Fujikawa T, Tamura A, Okuno Y, Wakamatsu M, Muramatsu H, Takahashi Y, Hasegawa D, Kosaka Y. Morishita Y, et al. Among authors: wakamatsu m. Pediatr Blood Cancer. 2025 Feb;72(2):e31465. doi: 10.1002/pbc.31465. Epub 2024 Nov 30. Pediatr Blood Cancer. 2025. PMID: 39616414
Novel mutation in KIF23 causing congenital dyserythropoietic anemia type III in patients who underwent allogeneic hematopoietic stem cell transplantation.
Fujikawa T, Uemura S, Hasegawa D, Morisada N, Nakamura S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T, Yakushijin K, Katayama Y, Yamashita D, Wakamatsu M, Hamada M, Muramatsu H, Takahashi Y, Kosaka Y. Fujikawa T, et al. Among authors: wakamatsu m. Pediatr Blood Cancer. 2024 Jun;71(6):e30736. doi: 10.1002/pbc.30736. Epub 2024 Mar 24. Pediatr Blood Cancer. 2024. PMID: 38523246 No abstract available.
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia.
Kitazawa H, Okuno Y, Muramatsu H, Aoki K, Murakami N, Wakamatsu M, Suzuki K, Narita K, Kataoka S, Ichikawa D, Hamada M, Taniguchi R, Kawashima N, Nishikawa E, Narita A, Nishio N, Hama A, Loh ML, Stieglitz E, Kojima S, Takahashi Y. Kitazawa H, et al. Among authors: wakamatsu m. Blood Adv. 2021 Dec 28;5(24):5507-5518. doi: 10.1182/bloodadvances.2021005080. Blood Adv. 2021. PMID: 34580726 Free PMC article.
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma.
Imaya M, Muramatsu H, Narita A, Yamamori A, Wakamatsu M, Yoshida T, Miwata S, Narita K, Ichikawa D, Hamada M, Nishikawa E, Kawashima N, Nishio N, Kojima S, Takahashi Y. Imaya M, et al. Among authors: wakamatsu m. Cancer Med. 2022 May;11(9):1956-1964. doi: 10.1002/cam4.4529. Epub 2022 Mar 1. Cancer Med. 2022. PMID: 35233973 Free PMC article.
Integrated proteogenomic analysis for inherited bone marrow failure syndrome.
Wakamatsu M, Muramatsu H, Sato H, Ishikawa M, Konno R, Nakajima D, Hamada M, Okuno Y, Kawashima Y, Hama A, Ito M, Iwafuchi H, Takahashi Y, Ohara O. Wakamatsu M, et al. Leukemia. 2024 Jun;38(6):1256-1265. doi: 10.1038/s41375-024-02263-1. Epub 2024 May 13. Leukemia. 2024. PMID: 38740980 Free PMC article.
Clinical Impact of Melphalan Pharmacokinetics on Transplantation Outcomes in Children Undergoing Hematopoietic Stem Cell Transplantation.
Maemura R, Wakamatsu M, Matsumoto K, Sakaguchi H, Yoshida N, Hama A, Yoshida T, Miwata S, Kitazawa H, Narita K, Kataoka S, Ichikawa D, Hamada M, Taniguchi R, Suzuki K, Kawashima N, Nishikawa E, Narita A, Okuno Y, Nishio N, Kato K, Kojima S, Morita K, Muramatsu H, Takahashi Y. Maemura R, et al. Among authors: wakamatsu m. Cell Transplant. 2022 Jan-Dec;31:9636897221143364. doi: 10.1177/09636897221143364. Cell Transplant. 2022. PMID: 36537564 Free PMC article.
Allogeneic stem cell transplantation with reduced intensity conditioning for patients with adrenoleukodystrophy.
Kato K, Maemura R, Wakamatsu M, Yamamori A, Hamada M, Kataoka S, Narita A, Miwata S, Sekiya Y, Kawashima N, Suzuki K, Narita K, Doisaki S, Muramatsu H, Sakaguchi H, Matsumoto K, Koike Y, Onodera O, Kaga M, Shimozawa N, Yoshida N. Kato K, et al. Among authors: wakamatsu m. Mol Genet Metab Rep. 2018 Nov 20;18:1-6. doi: 10.1016/j.ymgmr.2018.11.001. eCollection 2019 Mar. Mol Genet Metab Rep. 2018. PMID: 30519529 Free PMC article.
A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven.
Taniguchi R, Muramatsu H, Okuno Y, Yoshida T, Wakamatsu M, Hamada M, Shirota C, Sumida W, Hinoki A, Tainaka T, Gotoh Y, Tsuzuki T, Tanaka Y, Kojima S, Uchida H, Takahashi Y. Taniguchi R, et al. Among authors: wakamatsu m. Fam Cancer. 2022 Jul;21(3):337-341. doi: 10.1007/s10689-021-00268-8. Epub 2021 Jun 22. Fam Cancer. 2022. PMID: 34156580
150 results